NCT07418021

Brief Summary

This study investigates the effect of cold spray and Buzzy devices on pain and fear experienced during penicillin injections. There are three groups: a cold spray and Buzzy device, and a control group. Penicillin injections are commonly used in clinical practice and can cause discomfort, pain, and fear, particularly in patients receiving intramuscular injections. Cold spray and Buzzy devices are non-pharmacological methods that can help reduce pain and fear by providing a cooling effect and vibration at the injection site. Participants will be randomly assigned to one of the study groups, and their pain and fear levels during injection will be assessed using standardized measurement tools. The results of this study are expected to contribute to improving patient comfort and supporting the use of simple, non-invasive methods to reduce pain and fear during injections.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 21, 2026

Completed
15 days until next milestone

Study Start

First participant enrolled

February 5, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 18, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 5, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 5, 2026

Completed
Last Updated

February 18, 2026

Status Verified

February 1, 2026

Enrollment Period

2 months

First QC Date

January 21, 2026

Last Update Submit

February 10, 2026

Conditions

Keywords

PainInjectionInjection fear

Outcome Measures

Primary Outcomes (1)

  • Procedural Pain Intensity

    Procedural pain intensity will be measured using a 10-centimeter Visual Analog Scale (VAS), where 0 represents "no pain" and 10 represents "unbearable pain."

    Within one minute before the penicillin injection procedure.

Secondary Outcomes (1)

  • Level of Procedural Fear

    Immediately before the procedure and within 1 minute after the procedure.

Study Arms (3)

Control Group

ACTIVE COMPARATOR

In the Control group, a standard intramuscular penicillin injection is administered without any additional pain management intervention. All injections are performed using a standardized technique by the same nurse to ensure consistency.

Other: Control Group

Cold Spray Intervention Group

EXPERIMENTAL

Two minutes prior to the procedure, patients will receive a brief explanation about the device. One minute before the injection, a cold spray will be applied to the individual for 30 seconds. Routine procedures will be followed during the injection.

Other: Cold Spray Intervention Group

Buzy Device Intervention Group

EXPERIMENTAL

Two minutes prior to the procedure, patients will receive a brief explanation about the device. One minute before the injection, a cold spray will be applied to the individual for 30 seconds. Routine procedures will be followed during the injection.

Other: Buzy Device Intervention Group

Interventions

Cold spray application

Cold Spray Intervention Group

Buzzy device application

Buzy Device Intervention Group

Standard care

Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 years and older
  • Individuals scheduled to receive intramuscular penicillin injection
  • Able to communicate and report pain and fear levels
  • Willing to participate in the study
  • Provided written informed consent

You may not qualify if:

  • Known allergy or hypersensitivity to cold applications
  • Skin lesions, infection, or injury at the injection site
  • Neurological or psychiatric conditions that may affect pain or fear perception
  • Use of analgesic or anxiolytic medication prior to injection
  • Previous adverse reaction to intramuscular injections

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Yildiz GN, Ciftci B; Development of the Injection Fear Scale; Proceedings of the 1st International Uludağ Scientific Research Congress; 2023:1-2.

    RESULT
  • Çetin MM, Avşar G; Evaluation of the effect of cold spray application on injection pain during intramuscular penicillin injection; Mersin University Journal of Health Sciences; 2022;15(3):573-583.

    RESULT

MeSH Terms

Conditions

AgnosiaPainIatrophobia

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Central Study Contacts

Zeliha CENGIZ, Associate Professor Dr.

CONTACT

Sema K Kömürkara, Dr

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: A randomized controlled experimental study with 3 groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor Dr.

Study Record Dates

First Submitted

January 21, 2026

First Posted

February 18, 2026

Study Start

February 5, 2026

Primary Completion

April 5, 2026

Study Completion

May 5, 2026

Last Updated

February 18, 2026

Record last verified: 2026-02